Search Login Register
Crigler-Najjar Syndrome
(Syndrome, Crigler-Najjar)
Summary
Description:
A familial form of congenital hyperbilirubinemia transmitted as an autosomal recessive trait. It is characterized by icterus and brain damage caused by a glucuronyl transferase deficiency in the liver and faulty bilirubin conjugation.
Also Known As:
Syndrome, Crigler-Najjar; Crigler-Najar Syndrome; Crigler Najar Syndrome; Crigler Najjar Syndrome; Syndrome, Crigler-Najar
Networked: 172
relevant articles (4 outcomes,
10 trials/studies)
for this Disease
Key Drugs and Agents for Crigler-Najjar Syndrome
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Bilirubin
:
2 outcomes 4 studies in 87 results
: IBA
-
Factor VII (Proconvertin)
:
1 outcome in 1 result
: IBA
-
progressive familial intrahepatic 1 Cholestasis
:
1 outcome in 1 result
: IBA
-
4-O-carboxymethylascochlorin
:
1 outcome in 1 result
: IBA
-
Uridine Diphosphate (UDP)
:
2 studies in 20 results
: IBA
-
Transferases
:
2 studies in 16 results
: IBA
-
Glucuronosyltransferase (UDP Glucuronosyltransferase)
:
1 study in 35 results
: IBA
-
Glucuronides
:
1 study in 4 results
: IBA
-
Nonsense Codon (Nonsense Mutation)
:
1 study in 3 results
: IBA
-
Complementary DNA (cDNA)
:
1 study in 2 results
: IBA
Show All >>
Diseases Related to Crigler-Najjar Syndrome
-
Hyperbilirubinemia
-
Ornithine Carbamoyltransferase Deficiency Disease
-
Gilbert Disease
-
Jaundice
-
Neonatal Hyperbilirubinemia
Show All >>
Key Therapies for Crigler-Najjar Syndrome
Efficacy Chart >>
-
Liver Transplantation
:
1 outcome 1 study in 18 results
-
Homologous Transplantation (Allograft)
:
1 outcome in 1 result
-
Injections
:
1 outcome in 1 result
-
Transplantation (Transplant Recipients)
:
1 study in 9 results
-
Transplants (Transplant)
:
1 study in 6 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.